Transforming Growth Factor Beta Superfamily Members: Role in Cartilage Modeling

Normal and abnormal extracellular matrix turnover is thought to result, in part, from the balance in the expression of metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs). The clinical manifestations of an imbalance in these relationships are evident in a variety of pathologic states, including osteoarthritis, deficient long-bone growth, rheumatoid arthritis, tumor invasion, and inadequate cartilage repair. Articular cartilage defects commonly heal as fibrocartilage, which is structurally inferior to the normal hyaline architecture of articular cartilage. Transforming growth factor-beta 1 (TGF-&bgr;1), a cytokine central to growth, repair, and inflammation, has been shown to up-regulate TIMP-1 expression in human and bovine articular cartilage. Additionally, members of the TGF-&bgr; superfamily are thought to play key roles in chondrocyte growth and differentiation. Bone morphogenetic protein-2 (BMP-2), a member of this superfamily, has been shown to regulate chondrocyte differentiation states and extracellular matrix composition. It was proposed that, by optimizing extracellular matrix composition, BMP-2 would enhance articular cartilage healing. After determining the release kinetics of BMP-2 from a collagen type I implant (Long-Evans male rats; two implants/rat, n = 14), it was found that, in a tissue engineering application, BMP-2 induced a hyaline-like repair of New Zealand White rabbit knee articular cartilage defects (3-mm full-thickness defects in the femoral trochlea; 2 defects/rabbit, n = 36). The quality of cartilage repair with BMP-2 (with or without chondrocytes) was significantly better than defects treated with BMP-2, as assessed by a quantitative scoring scale. Immunohistochemical staining revealed TIMP-1 production in the cartilage defects treated with BMP-2. When studied in vitro, it was found that BMP-2 markedly increased TIMP-1 mRNA by both bovine articular and human rib chondrocytes. Additionally, increased TIMP-1 mRNA was translated into increased TIMP-1 protein production by bovine chondrocytes. Taken together, these data suggest that BMP-2 may be a useful cytokine to improve healing of cartilaginous defects. Furthermore, these data suggest that the beneficial effects of BMP-2 may be, in part, related to alterations in extracellular matrix turnover.

[1]  Mahlon D. Johnson,et al.  Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis , 1997, The Journal of cell biology.

[2]  E. Morris,et al.  The Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) on the Healing of Full-Thickness Defects of Articular Cartilage* , 1997, The Journal of bone and joint surgery. American volume.

[3]  J. Massagué,et al.  Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. , 1997, Genes & development.

[4]  M. Pitman,et al.  Chondrocyte transplantation using a collagen bilayer matrix for cartilage repair. , 1997, The Journal of bone and joint surgery. British volume.

[5]  W. B. van den Berg,et al.  Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. , 1997, Arthritis and rheumatism.

[6]  Tom Minas,et al.  Current concepts in the treatment of articular cartilage defects. , 1997, Orthopedics.

[7]  E. Canalis,et al.  Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. , 1997, Endocrinology.

[8]  J. McCarthy,et al.  Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. , 1997, Plastic and reconstructive surgery.

[9]  G. Naughton,et al.  Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. , 1997, Journal of biomedical materials research.

[10]  J. Pujol,et al.  Differential expression of membrane-anchored proteoglycans in rabbit articular chondrocytes cultured in monolayers and in alginate beads. Effect of transforming growth factor-beta 1. , 1997, Biochimica et biophysica acta.

[11]  H. Sato,et al.  Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. , 1996, The Journal of rheumatology.

[12]  L. Bonassar,et al.  Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties. , 1996, Archives of biochemistry and biophysics.

[13]  H. Alexander,et al.  Effects of growth-factor-enhanced culture on a chondrocyte-collagen implant for cartilage repair. , 1996, Journal of biomedical materials research.

[14]  C. Tickle,et al.  Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. , 1996, Developmental biology.

[15]  D Amiel,et al.  Articular cartilage repair using allogeneic perichondrocyte-seeded biodegradable porous polylactic acid (PLA): a tissue-engineering study. , 1995, Journal of biomedical materials research.

[16]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[17]  A. Reddi Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.

[18]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[19]  J. Hesketh,et al.  The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc. , 1993, Journal of cell science.

[20]  B. Henderson,et al.  Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. , 1993, The American journal of pathology.

[21]  P. Roughley,et al.  Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. , 1993, Matrix.

[22]  W. B. van den Berg,et al.  Inhibition of proteoglycan synthesis by transforming growth factor beta in anatomically intact articular cartilage of murine patellae. , 1992, Annals of the rheumatic diseases.

[23]  H. Inoue,et al.  Bone morphogenetic proteins (BMP‐2 and BMP‐3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3‐E1 cells in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  J. Dasch,et al.  Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. , 1990, Clinical orthopaedics and related research.

[25]  L. Peterson,et al.  The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  M. Iwamoto,et al.  Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Mauviel,et al.  Transforming growth factor β stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes , 1988 .

[28]  R. Hirai,et al.  Effect of transforming growth factor beta on cell proliferation and glycosaminoglycan synthesis by rabbit growth-plate chondrocytes in culture. , 1988, Biochimica et biophysica acta.

[29]  R. Salter,et al.  The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. An experimental investigation in the rabbit. , 1986, The Journal of bone and joint surgery. American volume.

[30]  D. Howell,et al.  Characterization of the metalloproteinase inhibitor produced by bovine articular chondrocyte cultures. , 1983, Biochimica et biophysica acta.

[31]  Alexander Marks,et al.  Role of antibody to S100 protein in diagnostic pathology. , 1983, American journal of clinical pathology.

[32]  D. Eyre,et al.  The distribution of different molecular species of collagen in fibrous, elastic and hyaline cartilages of the pig. , 1975, Biochemical Journal.

[33]  P. Heinrich,et al.  Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. , 1994, Arthritis and rheumatism.

[34]  A. Mauviel,et al.  Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. , 1993, Arthritis and rheumatism.

[35]  T Ochi,et al.  Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel. , 1989, The Journal of bone and joint surgery. British volume.

[36]  J. Puzas,et al.  Transforming growth factor beta: an autocrine regulator of chondrocytes. , 1989, Connective tissue research.

[37]  R. Coutts,et al.  The chondrogenesis of rib perichondrial grafts for repair of full thickness articular cartilage defects in a rabbit model: a one year postoperative assessment. , 1988, Connective tissue research.

[38]  L. Junqueira,et al.  Collagen arrangement in cartilages. , 1982, Acta anatomica.

[39]  M. Klagsbrun Large-scale preparation of chondrocytes. , 1979, Methods in enzymology.